JP2022525535A5 - - Google Patents
Info
- Publication number
- JP2022525535A5 JP2022525535A5 JP2021556422A JP2021556422A JP2022525535A5 JP 2022525535 A5 JP2022525535 A5 JP 2022525535A5 JP 2021556422 A JP2021556422 A JP 2021556422A JP 2021556422 A JP2021556422 A JP 2021556422A JP 2022525535 A5 JP2022525535 A5 JP 2022525535A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- nucleic acid
- antigen
- seq
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820495P | 2019-03-19 | 2019-03-19 | |
| US62/820,495 | 2019-03-19 | ||
| PCT/US2020/023600 WO2020191181A1 (en) | 2019-03-19 | 2020-03-19 | Monoclonal antibodies for prevention and treatment of herpes simplex viral infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525535A JP2022525535A (ja) | 2022-05-17 |
| JP2022525535A5 true JP2022525535A5 (enExample) | 2023-03-07 |
| JP7835392B2 JP7835392B2 (ja) | 2026-03-25 |
Family
ID=70285944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556422A Active JP7835392B2 (ja) | 2019-03-19 | 2020-03-19 | 単純ヘルペスウイルス感染の予防及び処置のためのモノクローナル抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12459987B2 (enExample) |
| EP (1) | EP3941524A1 (enExample) |
| JP (1) | JP7835392B2 (enExample) |
| KR (1) | KR20210141948A (enExample) |
| CN (2) | CN113661176B (enExample) |
| AU (1) | AU2020242042A1 (enExample) |
| CA (1) | CA3133862A1 (enExample) |
| IL (1) | IL286415A (enExample) |
| WO (1) | WO2020191181A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114805579B (zh) * | 2022-06-08 | 2023-06-06 | 郑州大学 | 一种抗人ace2蛋白单克隆抗体、核酸分子及应用 |
| TWI876557B (zh) * | 2022-09-30 | 2025-03-11 | 臺北醫學大學 | 用於前列腺癌診斷和早期發病的單株抗體 |
| CN119751660B (zh) * | 2024-12-02 | 2026-04-03 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 一种猫麻疹病毒特异性单克隆抗体及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| GB9115364D0 (en) | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
| CA2078539C (en) | 1991-09-18 | 2005-08-02 | Kenya Shitara | Process for producing humanized chimera antibody |
| US5714350A (en) | 1992-03-09 | 1998-02-03 | Protein Design Labs, Inc. | Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region |
| US6210671B1 (en) | 1992-12-01 | 2001-04-03 | Protein Design Labs, Inc. | Humanized antibodies reactive with L-selectin |
| US6180377B1 (en) | 1993-06-16 | 2001-01-30 | Celltech Therapeutics Limited | Humanized antibodies |
| AU1866895A (en) | 1994-01-04 | 1995-08-01 | Scripps Research Institute, The | Human monoclonal antibodies to herpes simplex virus and methods therefor |
| ES2375931T3 (es) | 1997-12-05 | 2012-03-07 | The Scripps Research Institute | Humanización de anticuerpo murino. |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| US6849425B1 (en) | 1999-10-14 | 2005-02-01 | Ixsys, Inc. | Methods of optimizing antibody variable region binding affinity |
| EP2308895A1 (en) * | 2009-10-01 | 2011-04-13 | Universität Duisburg-Essen | Anti-HSV antibody |
| ES2843277T3 (es) | 2014-06-26 | 2021-07-16 | Heidelberg Immunotherapeutics Gmbh | Aplicación tópica para un anticuerpo anti-VHS |
| JP2020504105A (ja) | 2016-12-19 | 2020-02-06 | グレンマーク・ファーマシューティカルズ・エスエー | 新規なｔｎｆｒアゴニストおよびその使用 |
| CN111148832A (zh) | 2017-08-30 | 2020-05-12 | Km生物医薬股份公司 | 抗HSV gB单克隆抗体或其抗原结合片段 |
-
2020
- 2020-03-19 EP EP20719007.5A patent/EP3941524A1/en active Pending
- 2020-03-19 CN CN202080021839.7A patent/CN113661176B/zh active Active
- 2020-03-19 JP JP2021556422A patent/JP7835392B2/ja active Active
- 2020-03-19 CN CN202510126123.8A patent/CN119899260A/zh active Pending
- 2020-03-19 AU AU2020242042A patent/AU2020242042A1/en active Pending
- 2020-03-19 KR KR1020217031401A patent/KR20210141948A/ko not_active Ceased
- 2020-03-19 CA CA3133862A patent/CA3133862A1/en active Pending
- 2020-03-19 WO PCT/US2020/023600 patent/WO2020191181A1/en not_active Ceased
- 2020-03-19 US US17/440,452 patent/US12459987B2/en active Active
-
2021
- 2021-09-14 IL IL286415A patent/IL286415A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024038003A5 (enExample) | ||
| US10344077B2 (en) | HIV-1 neutralizing antibodies and uses thereof (V3 antibodies) | |
| HRP20230338T1 (hr) | Anti-sars-cov-2-spike-glikoprotein antitijela i fragmenti za vezivanje antigena | |
| JP2025016349A5 (enExample) | ||
| JP2022553324A5 (enExample) | ||
| WO2021174595A1 (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| CN107226861B (zh) | 人源抗h7n9禽流感病毒中和性抗体1f7l及其应用 | |
| JP2018512863A5 (enExample) | ||
| CN115043938B (zh) | SARS-CoV-2及其突变株的抗体及应用 | |
| RU2018133708A (ru) | Антитела, обладающие специфичностью к btla, и их использование | |
| HRP20240774T1 (hr) | Anti-il-33 antitijela i njihove upotrebe | |
| CN116836269A (zh) | 抗呼吸道合胞病毒的单克隆抗体及其应用 | |
| RU2013102073A (ru) | Антитела, подходящие для пассивной иммунизации против гриппа | |
| RU2016134256A (ru) | Антитела против f гликопротеина вирусов хендра и нипах | |
| CN107056938B (zh) | 人源抗h7n9禽流感病毒高亲和力抗体10k及其应用 | |
| WO2017011413A1 (en) | Bispecific molecules comprising an hiv-1 envelope targeting arm | |
| CN113354730A (zh) | 一种抗新型冠状病毒的单克隆抗体及其应用 | |
| JP2018148915A5 (enExample) | ||
| JP2017504321A5 (enExample) | ||
| Burton et al. | Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory | |
| FI4031569T3 (fi) | Kantasolutekijän vasta-aineet ja niiden käyttömenetelmät | |
| WO2024125667A1 (zh) | 一种针对SARS-CoV或SARS-CoV-2的单克隆抗体、其制备方法及应用 | |
| RU2019104896A (ru) | Антитела к глюкокортикоид-индуцированному рецептору фактора некроза опухоли (gitr) и способы их использования | |
| AU2023371074A1 (en) | Anti-ccr8 antibody and use thereof | |
| JP2017536821A5 (enExample) |